The enzymatic activity of apoptosis-inducing factor supports energy metabolism benefiting the growth and invasiveness of advanced prostate cancer cells

Journal of Biological Chemistry

Volumn 287, Issue 52, 2012, Pages 43862-43875

  Lewis, Eric M ^a,e   Wilkinson, Amanda S ^a   Jackson, Jacqueline S ^a,f   Mehras, Rohit ^b,c   Varamballys, Sooryanarayana ^b,c,d   Chinnaiyan, Arul M ^b,c,d   Wilkinson, John C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e HIGH POINT UNIVERSITY   (United States)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS-INDUCING FACTORS; CELL LINES; CELL SURVIVAL; CELL TOXICITY; ENERGY METABOLISM; ENZYMATIC ACTIVITIES; GENE EXPRESSION DATA; GLUCOSE METABOLISM; GROWTH STRESS; HUMAN DISEASE; HUMAN PROSTATE CANCER; IN-VIVO; INVASIVENESS; LNCAP CELLS; MITOCHONDRIAL COMPLEX; PROSTATE CANCER CELLS; PROSTATE CANCERS; PROSTATE TUMOR; PROTEIN SUBUNITS; REDOX BALANCES; SUBSTANTIAL REDUCTION; TRANSCRIPT LEVEL;

CELL CULTURE; DISEASES; GENE EXPRESSION; GLUCOSE; METABOLISM; PROTEINS;

CELL DEATH;

APOPTOSIS INDUCING FACTOR; MITOCHONDRIAL COMPLEX I PROTEIN SUBUNIT; MITOCHONDRIAL PROTEIN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENERGY METABOLISM; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

APOPTOSIS INDUCING FACTOR; CELL LINE, TUMOR; CELL SURVIVAL; ELECTRON TRANSPORT COMPLEX I; ENERGY METABOLISM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OXIDATION-REDUCTION; PROSTATIC NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 84871595609     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.407650     Document Type: Article

References (67)

1. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D. R., Aebersold, R., Siderovski, D. P., Penninger, J. M., and Kroemer, G. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446
2. Wang, X., Yang, C., Chai, J., Shi, Y., and Xue, D. (2002) Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science 298, 1587-1592 (Pubitemid 35387191)
3. Loeffler, M., Daugas, E., Susin, S. A., Zamzami, N., Metivier, D., Nieminen, A. L., Brothers, G., Penninger, J. M., and Kroemer, G. (2001) Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J. 15, 758-767 (Pubitemid 32245994)
4. Miramar, M. D., Costantini, P., Ravagnan, L., Saraiva, L. M., Haouzi, D., Brothers, G., Penninger, J. M., Peleato, M. L., Kroemer, G., and Susin, S. A. (2001) NADH oxidase activity of mitochondrial apoptosis-inducing factor. J. Biol. Chem. 276, 16391-16398
5. Brown, D., Yu, B. D., Joza, N., Bénit, P., Meneses, J., Firpo, M., Rustin, P., Penninger, J. M., and Martin, G. R. (2006) Loss of AIF function causes cell death in the mouse embryo, but the temporal progression of patterning is normal. Proc. Natl. Acad. Sci. U.S.A. 103, 9918-9923 (Pubitemid 43993598)
6. Klein, J. A., Longo-Guess, C. M., Rossmann, M. P., Seburn, K. L., Hurd, R. E., Frankel, W. N., Bronson, R. T., and Ackerman, S. L. (2002) The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419, 367-374
7. Vahsen, N., Candé, C., Brière, J. J., Bénit, P., Joza, N., Larochette, N., Mastroberardino, P. G., Pequignot, M. O., Casares, N., Lazar, V., Feraud, O., Debili, N., Wissing, S., Engelhardt, S., Madeo, F., Piacentini, M., Penninger, J. M., Schägger, H., Rustin, P., and Kroemer, G. (2004) AIF deficiency compromises oxidative phosphorylation. EMBO J. 23, 4679-4689 (Pubitemid 39657867)
8. Joza, N., Oudit, G. Y., Brown, D., Bénit, P., Kassiri, Z., Vahsen, N., Benoit, L., Patel, M. M., Nowikovsky, K., Vassault, A., Backx, P. H., Wada, T., Kroemer, G., Rustin, P., and Penninger, J. M. (2005) Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol. Cell. Biol. 25, 10261-10272 (Pubitemid 41681953)
9. Cheung, E. C., Joza, N., Steenaart, N. A., McClellan, K. A., Neuspiel, M., McNamara, S., MacLaurin, J. G., Rippstein, P., Park, D. S., Shore, G. C., McBride, H. M., Penninger, J. M., and Slack, R. S. (2006) Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. EMBO J. 25, 4061-4073 (Pubitemid 44338747)
10. Ghezzi, D., Sevrioukova, I., Invernizzi, F., Lamperti, C., Mora, M., D'Adamo, P., Novara, F., Zuffardi, O., Uziel, G., and Zeviani, M. (2010) Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. Am. J. Hum. Genet. 86, 639-649
11. Porter, A. G., and Urbano, A. G. (2006) Does apoptosis-inducing factor (AIF) have both life and death functions in cells? Bioessays 28, 834-843 (Pubitemid 44433745)
12. Urbano, A., Lakshmanan, U., Choo, P. H., Kwan, J. C., Ng, P. Y., Guo, K., Dhakshinamoorthy, S., and Porter, A. (2005) AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells. EMBO J. 24, 2815-2826 (Pubitemid 41170030)
13. Movsas, B., Chapman, J. D., Horwitz, E. M., Pinover, W. H., Greenberg, R. E., Hanlon, A. L., Iyer, R., and Hanks, G. E. (1999) Hypoxic regions exist in human prostate carcinoma. Urology 53, 11-18 (Pubitemid 29016607)
14. Williams, K. J., Cowen, R. L., and Stratford, I. J. (2001) Hypoxia and oxidative stress. Tumour hypoxia. Therapeutic considerations. Breast Cancer Res. 3, 328-331 (Pubitemid 32851164)
15. Ghafar, M. A., Anastasiadis, A. G., Chen, M. W., Burchardt, M., Olsson, L. E., Xie, H., Benson, M. C., and Buttyan, R. (2003) Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells. Prostate 54, 58-67 (Pubitemid 36043837)
16. Pinthus, J. H., Bryskin, I., Trachtenberg, J., Lu, J. P., Singh, G., Fridman, E., and Wilson, B. C. (2007) Androgen induces adaptation to oxidative stress in prostate cancer. Implications for treatment with radiation therapy. Neoplasia 9, 68-80 (Pubitemid 46203935)
17. Bhat, H. K., Calaf, G., Hei, T. K., Loya, T., and Vadgama, J. V. (2003) Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 100, 3913-3918 (Pubitemid 36418131)
18. Morgan, M. J., and Liu, Z. G. (2011) Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 21, 103-115
19. Dang, C. V. (2012) Links between metabolism and cancer. Genes Dev. 26, 877-890
20. Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S., Michalopoulos, G., Becich, M., and Luo, J. H. (2004) Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol. 22, 2790-2799 (Pubitemid 41079896)
21. Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., Antipin, Y., Mitsiades, N., Landers, T., Dolgalev, I., Major, J. E., Wilson, M., Socci, N. D., Lash, A. E., Heguy, A., Eastham, J. A., Scher, H. I., Reuter, V. E., Scardino, P. T., Sander, C., Sawyers, C. L., and Gerald, W. L. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11-22
22. Liu, P., Ramachandran, S., Ali Seyed, M., Scharer, C. D., Laycock, N., Dalton, W. B., Williams, H., Karanam, S., Datta, M. W., Jaye, D. L., and Moreno, C. S. (2006) Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res. 66, 4011-4019
23. Holzbeierlein, J., Lal, P., LaTulippe, E., Smith, A., Satagopan, J., Zhang, L., Ryan, C., Smith, S., Scher, H., Scardino, P., Reuter, V., and Gerald, W. L. (2004) Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am. J. Pathol. 164, 217-227 (Pubitemid 38364606)
24. Wallace, T. A., Prueitt, R. L., Yi, M., Howe, T. M., Gillespie, J. W., Yfantis, H. G., Stephens, R. M., Caporaso, N. E., Loffredo, C. A., and Ambs, S. (2008) Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res. 68, 927-936 (Pubitemid 351206772)
25. Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U., Ekman, P., DeMarzo, A. M., Tibshirani, R., Botstein, D., Brown, P. O., Brooks, J. D., and Pollack, J. R. (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 101, 811-816 (Pubitemid 38121040)
26. Arredouani, M. S., Lu, B., Bhasin, M., Eljanne, M., Yue, W., Mosquera, J. M., Bubley, G. J., Li, V., Rubin, M. A., Libermann, T. A., and Sanda, M. G. (2009) Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer. Clin. Cancer Res. 15, 5794-5802
27. Luo, J. H., Yu, Y. P., Cieply, K., Lin, F., Deflavia, P., Dhir, R., Finkelstein, S., Michalopoulos, G., and Becich, M. (2002) Gene expression analysis of prostate cancers. Mol. Carcinog. 33, 25-35 (Pubitemid 34052304)
28. Vanaja, D. K., Cheville, J. C., Iturria, S. J., and Young, C. Y. (2003) Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Res. 63, 3877-3882 (Pubitemid 36917897)
29. LaTulippe, E., Satagopan, J., Smith, A., Scher, H., Scardino, P., Reuter, V., and Gerald, W. L. (2002) Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 62, 4499-4506 (Pubitemid 34827314)
30. Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang-Rodriguez, J., Moskaluk, C. A., Frierson, H. F., Jr., and Hampton, G. M. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974-5978 (Pubitemid 32762523)
31. Singh, D., Febbo, P. G., Ross, K., Jackson, D. G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A. A., D'Amico, A. V., Richie, J. P., Lander, E. S., Loda, M., Kantoff, P. W., Golub, T. R., and Sellers, W. R. (2002) Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1, 203-209 (Pubitemid 41039166)
32. Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., Shah, R. B., and Chinnaiyan, A. M. (2007) Integrative molecular concept modeling of prostate cancer progression. Nat. Genet. 39, 41-51 (Pubitemid 46026500)
33. Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G., Otte, A. P., Rubin, M. A., and Chinnaiyan, A. M. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624-629
34. Rhodes, D. R., Kalyana-Sundaram, S., Mahavisno, V., Varambally, R., Yu, J., Briggs, B. B., Barrette, T. R., Anstet, M. J., Kincead-Beal, C., Kulkarni, P., Varambally, S., Ghosh, D., and Chinnaiyan, A. M. (2007) Oncomine 3.0. Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9, 166-180
35. Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U., Monzon, F. A., Becich, M. J., Wei, J. T., Pienta, K. J., Ghosh, D., Rubin, M. A., and Chinnaiyan, A. M. (2005) Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8, 393-406 (Pubitemid 41579834)
36. Rubin, M. A., Zhou, M., Dhanasekaran, S. M., Varambally, S., Barrette, T. R., Sanda, M. G., Pienta, K. J., Ghosh, D., and Chinnaiyan, A. M. (2002) α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 287, 1662-1670 (Pubitemid 34289218)
37. Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., and Chinnaiyan, A. M. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822-826 (Pubitemid 32801464)
38. Yu, J., Wang, P., Ming, L., Wood, M. A., and Zhang, L. (2007) SMAC/Diablo mediates the proapoptotic function of PUMA by regulating PUMA-induced mitochondrial events. Oncogene 26, 4189-4198 (Pubitemid 46975795)
39. Kamradt, M. C., Lu, M., Werner, M. E., Kwan, T., Chen, F., Strohecker, A., Oshita, S., Wilkinson, J. C., Yu, C., Oliver, P. G., Duckett, C. S., Buchsbaum, D. J., LoBuglio, A. F., Jordan, V. C., and Cryns, V. L. (2005) The small heat shock protein αB-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3. J. Biol. Chem. 280, 11059-11066 (Pubitemid 40418409)
40. Qin, X. F., An, D. S., Chen, I. S., and Baltimore, D. (2003) Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. U.S.A. 100, 183-188 (Pubitemid 36078049)
41. Wilkinson, J. C., Wilkinson, A. S., Galbán, S., Csomos, R. A., and Duckett, C. S. (2008) Apoptosis-inducing factor is a target for ubiquitination through interaction with XIAP. Mol. Cell. Biol. 28, 237-247
42. Cao, P., Deng, Z., Wan, M., Huang, W., Cramer, S. D., Xu, J., Lei, M., and Sui, G. (2010) MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β. Mol. Cancer 9, 108
43. Galbán, S., Hwang, C., Rumble, J. M., Oetjen, K. A., Wright, C. W., Boudreault, A., Durkin, J., Gillard, J. W., Jaquith, J. B., Morris, S. J., and Duckett, C. S. (2009) Cytoprotective effects of IAPs revealed by a small molecule antagonist. Biochem. J. 417, 765-771
44. Liang, C. C., Park, A. Y., and Guan, J. L. (2007) In vitro scratch assay. A convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2, 329-333 (Pubitemid 47040047)
45. Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., Liu, X., and Wu, H. (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4, 209-221 (Pubitemid 37163835)
46. Zhang, W., Zhang, C., Narayani, N., Du, C., and Balaji, K. C. (2007) Nuclear translocation of apoptosis inducing factor is associated with cisplatin induced apoptosis in LNCaP prostate cancer cells. Cancer Lett. 255, 127-134 (Pubitemid 47212614)
47. Troutaud, D., Petit, B., Bellanger, C., Marin, B., Gourin-Chaury, M. P., Petit, D., Olivrie, A., Feuillard, J., Jauberteau, M. O., and Bordessoule, D. (2010) Prognostic significance of BAD and AIF apoptotic pathways in diffuse large B-cell lymphoma. Clin. Lymphoma Myeloma Leuk. 10, 118-124
48. Skyrlas, A., Hantschke, M., Passa, V., Gaitanis, G., Malamou-Mitsi, V., and Bassukas, I. D. (2011) Expression of apoptosis-inducing factor (AIF) in keratoacanthomas and squamous cell carcinomas of the skin. Exp. Dermatol. 20, 674-676
49. Li, S., Wan, M., Cao, X., and Ren, Y. (2011) Expression of AIF and HtrA2/Omi in small lymphocytic lymphoma and diffuse large B-cell lymphoma. Arch. Pathol Lab. Med. 135, 903-908
50. Huerta, S., Heinzerling, J. H., Anguiano-Hernandez, Y. M., Huerta-Yepez, S., Lin, J., Chen, D., Bonavida, B., and Livingston, E. H. (2007) Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells. Roles of Fas, Apaf-1, NFκB, IAPs, Smac/DIABLO, and AIF. J. Surg. Res. 142, 184-194 (Pubitemid 47277413)
51. Jeong, E. G., Lee, J. W., Soung, Y. H., Nam, S. W., Kim, S. H., Lee, J. Y., Yoo, N. J., and Lee, S. H. (2006) Immunohistochemical and mutational analysis of apoptosis-inducing factor (AIF) in colorectal carcinomas. APMIS 114, 867-873 (Pubitemid 44967322)
52. Millan, A., and Huerta, S. (2009) Apoptosis-inducing factor and colon cancer. J. Surg. Res. 151, 163-170
53. Norris, J. L., and Baldwin, A. S., Jr. (1999) Oncogenic Ras enhances NF-κB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways. J. Biol. Chem. 274, 13841-13846
54. Duesbery, N. S., Resau, J., Webb, C. P., Koochekpour, S., Koo, H. M., Leppla, S. H., and Vande Woude, G. F. (2001) Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc. Natl. Acad. Sci. U.S.A. 98, 4089-4094 (Pubitemid 32249903)
55. Yu, Q., Ciemerych, M. A., and Sicinski, P. (2005) Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins. Oncogene 24, 7114-7119 (Pubitemid 41573640)
56. Lewis, E. M., Wilkinson, A. S., Davis, N. Y., Horita, D. A., and Wilkinson, J. C. (2011) Nondegradative ubiquitination of apoptosis inducing factor (AIF) by X-linked inhibitor of apoptosis at a residue critical for AIF-mediated chromatin degradation. Biochemistry 50, 11084-11096
57. Devi, G. R. (2004) XIAP as target for therapeutic apoptosis in prostate cancer. Drug News Perspect 17, 127-134
58. Warburg, O. (1956) On the origin of cancer cells. Science 123, 309-314
59. Shanware, N. P., Mullen, A. R., DeBerardinis, R. J., and Abraham, R. T. (2011) Glutamine. Pleiotropic roles in tumor growth and stress resistance. J. Mol. Med. 89, 229-236
60. DeBerardinis, R. J., and Thompson, C. B. (2012) Cellular metabolism and disease. What do metabolic outliers teach us? Cell 148, 1132-1144
61. Bernard, D., Pourtier-Manzanedo, A., Gil, J., and Beach, D. H. (2003) Myc confers androgen-independent prostate cancer cell growth. J. Clin. Invest. 112, 1724-1731 (Pubitemid 38063730)
62. Ravi, R. K., McMahon, M., Yangang, Z., Williams, J. R., Dillehay, L. E., Nelkin, B. D., and Mabry, M. (1999) Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells. J. Cell. Biochem. 72, 458-469 (Pubitemid 29088298)
63. Mabjeesh, N. J., Willard, M. T., Frederickson, C. E., Zhong, H., and Simons, J. W. (2003) Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3′-kinase/protein kinase B in prostate cancer cells. Clin. Cancer Res. 9, 2416-2425 (Pubitemid 36842080)
64. Mehraein-Ghomi, F., Basu, H. S., Church, D. R., Hoffmann, F. M., and Wilding, G. (2010) Androgen receptor requires JunD as a coactivator to switch on an oxidative stress generation pathway in prostate cancer cells. Cancer Res. 70, 4560-4568
65. Shiota, M., Yokomizo, A., Tada, Y., Inokuchi, J., Kashiwagi, E., Masubuchi, D., Eto, M., Uchiumi, T., and Naito, S. (2010) Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression. Oncogene 29, 237-250
66. Biswas, M., and Chan, J. Y. (2010) Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicol. Appl. Pharmacol. 244, 16-20
67. Kaspar, J. W., Niture, S. K., and Jaiswal, A. K. (2009) Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med. 47, 1304-1309